Man­u­fac­tur­ing roundup: Cy­ti­va part­ners with Au­risco to build site for oligonu­cleotides; Eu­roAPI in­vest­ing €40M to boost pro­duc­tion

The Chi­nese CD­MO Au­risco is link­ing up with Cy­ti­va to build a plat­form to pro­duce oligonu­cleotides.

Dubbed the Oglio Flex­Fa­cotry plat­form, the com­pa­nies tout the line as a faster and more ef­fi­cient way to make oligonu­cleotides.  It will be the first of three new com­mer­cial man­u­fac­tur­ing lines that Au­risco is build­ing in Yangzhou, Chi­na. The site will be plan­ning to pro­duce 200 kilo­grams of oligonu­cleotides an­nu­al­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER